Corporate resilience during COVID-19

During a market collapse, it is strategically important for a company to be evaluated as resilient, thereby maintaining trust among investors. The authors study whether during the 2020 COVID-19 induced market crash, investors differentiate across companies based on a firm’s human capital, supply chain and operating crisis response. Using data derived from natural language processing of news around corporate responses to the coronavirus crisis, they find that companies with more positive sentiment exhibit higher institutional investor money flows and less negative returns than their competitors. This is especially true for companies with more salient responses.

Corporate Resilience and Response during COVID19_April 20

Sponsored Content

Leave a Comment

Europe’s response to COVID-19

Europe’s response to COVID-19

European real GDP is now projected to contract by 7 per cent in 2020, its biggest decline since World War II, followed by a rebound of 4.7 per cent in 2021. But the recovery’s strength will depend crucially on the course of the pandemic, people’s behavior, and the degree of continued economic policy support. 

Sort content by

COVID-19 treatment and vaccine tracker

The Milken Institute is tracking the development of treatments and vaccines for COVID-19. There are currently more than 2.5 million confirmed cases globally, 114 treatments in consideration and 79 vaccines in development.

Pandemic I: The first modern pandemic

In this memo Bill Gates shares his views of how to accelerate global innovation, which is the key to limiting the damage to society and the economy. This includes innovations in testing, treatments, vaccines, and policies to limit the spread while minimizing the damage to economies and well-being.

The economics of a pandemic

This lecture by professors of economics at the London Business School looks at the science, health policies, economics and macroeconomic policies related to COVID-19.

How the G20 can hasten recovery

This report argues the G20 not only should but can be meaningfully useful to recovery from the COVID-19 pandemic. It looks at the role of G20 in designing a fiscal response, strengthening access to vital medical supplies and ensuring global food security.

COVID-induced economic uncertainty

This paper identifies three indicators – stock market volatility, newspaper-based economic uncertainty, and subjective uncertainty in business expectation surveys – that provide real-time forward-looking uncertainty measures and illustrate how they can be used to assess the macroeconomic impact of the COVID-19 crisis. It implies a year-on-year contraction in US real GDP of nearly 11 per cent as of 2020 Q4

COVID-19: Implications for business

In this note McKinsey & Company offers its latest insights on the COVID-19 pandemic, starting with a survey of the current epidemiology and the five dynamics leaders need to watch.